The specification describes the sequences for two T-cell receptors--one having a high affinity and one having low affinity for the HLA-A2-restricted peptide PR1. Use of the T-cell receptors and variants thereof in the diagnosis and treatment of cancer and immune-related diseases are also provided.

 
Web www.patentalert.com

< Osteogenic Growth Peptide Fusion Proteins

> Non-Natural Sphingolipid Analogs and Uses Thereof

~ 00417